Replies to post #802917 on NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

10s of millions is $10-20 Million?
Cool math. Are you retarded?
That could have meat $90 million or a lot more. And yet, it was only an estimate.
It's obvious now how you got sucked into buying this stock. You don't understand #s

[learningcurve2020]

Think about that. I wonder how much cash Cognate had at the time it was taken over?

>>Cognate has provided manufacturing and regulatory assistance to NW Bio in the US since 2004, in Israel since 2008 and in Europe since 2010.

>>Charles River estimates the current market for Cognate’s manufacturing operations—mainly in cell therapy and plasmid production—is somewhere in the vicinity of $1.5 billion now and could grow at least 25% annually for the next five years.

RELATED: Fujifilm continues CMDO expansion spree with $76M in funding for new Boston site

Meanwhile, Cognate is expected to pull annual revenue of about $140 million this year and is on track to grow 25% per year over the next half-decade, Charles River said. If the deal closes in the first quarter as planned, it could boost Charles River’s 2021 revenue by $110 million, the company said.